Azad Saei Post Doctoral fellow (Karolinska Institutet); PhD (National University of Singapore); MSc. (Tehran University of Medical Sciences); BSc. (University of Tehran)
Postdoctoral Research Fellow, Karolinska Institutet, Stockholm, Stockholm County · Sweden
Editorial leadership for Journal of Bone Marrow Biology
Research interests
- Dendritic Cell Biology
- Immunotherapy
- Innate Immunity
- Transgenic Technology
Biography
Dr. Azad Saei (PhD, MSc, BSc) is a Postdoctoral Research Fellow at Karolinska Institutet in Stockholm, Sweden. He received his education from the University of Tehran, Tehran University of Medical Sciences, National University of Singapore, and Karolinska Institutet. His research encompasses immunology and cancer biology, with notable contributions to understanding immune responses in cancer therapy, including studies on Toxoplasma gondii protein fractions against melanoma and dendritic cell maturation induced by Listeria monocytogenes. His work also extends to bladder cancer progression mechanisms and tolerogenic dendritic cells in health and disease. His most-cited publication, "c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression" (2019), has received 55 citations.
Selected publications
- c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression 2019 cited 55×
- Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies 2018 cited 49×
- Ubiquitination and adaptive responses to BRAF inhibitors in Melanoma 2018 cited 9×
- Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression 2019 cited 1×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBMB for your work?
This journal is guided by Azad Saei (Postdoctoral Research Fellow, Karolinska Institutet, Stockholm, Stockholm County) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.